Related Experiment Videos

Worldwide perspective in transfusion safety: Europe

H W Reesink¹, P E Strengers

¹Blood Bank Noord Holland, Amsterdam region (Sanquin), The Netherlands.

Developments in Biologicals

|May 4, 2000

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow-up.

Journal of viral hepatitis·2017

Sofosbuvir plus simeprevir for the treatment of HCV genotype 4 patients with advanced fibrosis or compensated cirrhosis is highly efficacious in real life.

Journal of viral hepatitis·2016

Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Effect and side-effects of alpha interferon treatment in haemophilia patients with chronic hepatitis C.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAg-positive chronic hepatitis B patients treated with peginterferon and adefovir.

Antiviral research·2016

HLA-C and KIR combined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy.

Journal of viral hepatitis·2016

See all related articles